JAMP EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 300 MG
TENOFOVIR DISOPROXIL FUMARATE : 300 MG EMTRICITABINE : 200 MG · DIN 02487012 · JAMP PHARMA CORPORATION
Health Canada status: MARKETED
What is JAMP EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE?
JAMP EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 300 MG contains TENOFOVIR DISOPROXIL FUMARATE : 300 MG EMTRICITABINE : 200 MG. It is listed in the Health Canada Drug Product Database under DIN 02487012, held by JAMP PHARMA CORPORATION, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 23-Jul-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02487012 |
|---|---|
| Brand name | JAMP EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE |
| Generic / active ingredient | TENOFOVIR DISOPROXIL FUMARATE : 300 MG EMTRICITABINE : 200 MG |
| Manufacturer | JAMP PHARMA CORPORATION |
| Strength | 300 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | J05AR03 TENOFOVIR DISOPROXIL AND EMTRICITABINE |
| AHFS class | 28:08.92 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 23-Jul-2019 |
| Original market date | 2020-01-14 00:00:00 |
Is TENOFOVIR DISOPROXIL AND EMTRICITABINE in shortage in Canada?
A Canadian shortage report is on file for this molecule: Active — reported by SIVEM PHARMACEUTICALS ULC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
Check availability for JAMP EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
What can be used instead?
Other Canadian products sharing ATC code J05AR03 TENOFOVIR DISOPROXIL AND EMTRICITABINE. 9 of 10 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| AG-EMTRICITABINE / TENOFOVIR DISOPROXIL FUMARATE | 200 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02496356 |
| APO-EMTRICITABINE-TENOFOVIR | 300 MG | TABLET | APOTEX INC | MARKETED | DIN 02452006 |
| AURO-EMTRICITABINE-TENOFOVIR | 200 MG | TABLET | AURO PHARMA INC | MARKETED | DIN 02490684 |
| MINT-EMTRICITABINE/TENOFOVIR | 200 MG | TABLET | MINT PHARMACEUTICALS INC | MARKETED | DIN 02521547 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 200 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED | DIN 02443902 |
| PMS-EMTRICITABINE-TENOFOVIR | 300 MG | TABLET | PHARMASCIENCE INC | MARKETED | DIN 02461110 |
| TEVA-EMTRICITABINE/TENOFOVIR | 200 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02399059 |
| TRUVADA | 200 MG | TABLET | GILEAD SCIENCES CANADA INC | MARKETED | DIN 02274906 |
| SANDOZ EMTRICITABINE-TENOFOVIR | 200 MG | TABLET | SANDOZ CANADA INCORPORATED | CANCELLED PRE MARKET | DIN 02487853 |
Who else supplies TENOFOVIR DISOPROXIL AND EMTRICITABINE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. TENOFOVIR DISOPROXIL AND EMTRICITABINE appears in 726 registered pack listings across 13 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Request a quote for JAMP EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.